Sandoz Fentanyl Transdermal System



Indications and Reactions:

Role Indications Reactions
Primary
Pain 23.3%
Back Pain 14.1%
Product Used For Unknown Indication 9.8%
Hypertension 6.7%
Breakthrough Pain 6.0%
Depression 4.3%
Fibromyalgia 3.5%
Anxiety 3.2%
Cardiac Disorder 3.1%
Arthralgia 3.0%
Diabetes Mellitus 2.9%
Blood Pressure 2.7%
Sleep Disorder 2.7%
Muscle Spasms 2.5%
Blood Cholesterol 2.3%
Arthritis 2.3%
Pain In Extremity 2.0%
Drug Use For Unknown Indication 1.9%
Blood Cholesterol Increased 1.8%
Rheumatoid Arthritis 1.8%
Wrong Technique In Drug Usage Process 65.0%
Product Quality Issue 9.5%
Withdrawal Syndrome 3.7%
Treatment Noncompliance 3.5%
Vomiting 2.8%
Weight Decreased 2.3%
Pain 1.6%
Inappropriate Schedule Of Drug Administration 1.4%
Therapeutic Response Decreased 1.4%
Drug Administered At Inappropriate Site 1.2%
Inadequate Analgesia 1.1%
Drug Dose Omission 0.9%
Overdose 0.9%
Product Adhesion Issue 0.9%
Insomnia 0.7%
Off Label Use 0.7%
Somnolence 0.7%
Tremor 0.7%
Drug Ineffective 0.5%
Nausea 0.5%
Secondary
Pain 21.6%
Back Pain 16.9%
Hypertension 8.1%
Breakthrough Pain 6.1%
Product Used For Unknown Indication 5.7%
Fibromyalgia 5.5%
Arthralgia 4.8%
Arthritis 3.3%
Depression 3.3%
Chest Pain 3.2%
Pain In Extremity 3.0%
Neck Pain 2.6%
Sleep Disorder 2.4%
Anxiety 2.2%
Muscle Spasms 2.2%
Cardiac Disorder 2.1%
Rheumatoid Arthritis 2.0%
Neuropathy Peripheral 1.8%
Blood Cholesterol 1.7%
Blood Pressure 1.6%
Wrong Technique In Drug Usage Process 58.0%
Vomiting 6.3%
Product Quality Issue 6.1%
Withdrawal Syndrome 5.6%
Weight Decreased 3.3%
Product Adhesion Issue 3.1%
Therapeutic Response Decreased 3.1%
Treatment Noncompliance 2.8%
Urticaria 1.6%
Inappropriate Schedule Of Drug Administration 1.2%
Pain 1.2%
Stress 1.0%
Meniscus Injury 0.9%
Meniscus Lesion 0.9%
Rash Generalised 0.9%
Restlessness 0.9%
Weight Increased 0.9%
Back Disorder 0.7%
Insomnia 0.7%
Nausea 0.7%
Concomitant
Pain Management 100.0%
Wrong Technique In Drug Usage Process 100.0%